Specifically, the FDA has approved semaglutide for adults who are clinically obese (BMI of 30 or higher) or overweight (BMI of 27 or higher) when accompanied by at least one weight-related health condition, such as hypertension, hyperlipidemia, cardiovascular disease, prediabetes, or obstructive sleep apnea
Ongoing studies, such as the "Arm Laxity and Loss of Tone" trial combining liftHD and Pure Impact (1-2 Sofwave sessions + 4 Pure Impact treatments), demonstrate outcomes of enhanced muscle strength, muscle toning, and skin laxity improvement
But depending on the supplying pharmacy may or may not supply the U.K
Bulk drug substances used in compounding, Category 2 list
What can be the treatment period of Accutane